(Total Views: 493)
Posted On: 08/03/2021 3:56:44 PM
Post# of 154979
Hey, Bugeater,
Nope - you've never missed a post from me - I have never had a post deleted on this board.
I fully expected a mixed response.
I thought only one was misinformed - the person that said Endpoints was known as a biased rag. No, they are extremely widely read and trusted by people who work in pharma - not the investing crowd.
As for the others that objected - I in no way said the article was correct or balanced. I just said we were in a bigger hole with a broader audience than we previously were.
That was market-relevant news - the big people on this board can stand to hear it. Some of them will take the constructive step of educating the writer (go Ken). I may do the same.
Nope - you've never missed a post from me - I have never had a post deleted on this board.
I fully expected a mixed response.
I thought only one was misinformed - the person that said Endpoints was known as a biased rag. No, they are extremely widely read and trusted by people who work in pharma - not the investing crowd.
As for the others that objected - I in no way said the article was correct or balanced. I just said we were in a bigger hole with a broader audience than we previously were.
That was market-relevant news - the big people on this board can stand to hear it. Some of them will take the constructive step of educating the writer (go Ken). I may do the same.
(12)
(0)
